 |
|
Medication Related Osteonecrosis of the Jaw: 2021 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons
Jin-Woo Kim, Mi Kyung Kwak, Jeong Joon Han, Sung-Tak Lee, Ha Young Kim, Se Hwa Kim, Junho Jung, Jeong Keun Lee, Young-Kyun Lee, Yong-Dae Kwon, Deog-Yoon Kim
J Bone Metab. 2021;28(4):279-296. Published online 2021 Nov 30 DOI: https://doi.org/10.11005/jbm.2021.28.4.279
|
|
Citations to this article as recorded by
 Zoledronate/Anti-VEGF Neutralizing Antibody Combination Administration Increases Osteal Macrophages in a Murine Model of MRONJ Stage 0-like Lesions
Haruka Kaneko, Shinichiro Kuroshima, Ryohei Kozutsumi, Farah A. Al-Omari, Hiroki Hayano, Kazunori Nakajima, Takashi Sawase
Journal of Clinical Medicine.2023; 12(5): 1914. CrossRef Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw
Sebastian Blatt, Maximilian Krüger, Peer W. Kämmerer, Daniel G. E. Thiem, Philipp Matheis, Anne-Katrin Eisenbeiß, Jörg Wiltfang, Bilal Al-Nawas, Hendrik Naujokat
Journal of Clinical Medicine.2022; 11(3): 682. CrossRef Medication-Related Osteonecrosis of the Jaws: A Literature Review
Gyeong-Mi Kim, Seong-Yong Moon, Jae-Seek You, Gyeong-Yun Kim, Ji-Su Oh
Journal of Oral Medicine and Pain.2022; 47(1): 1. CrossRef Relationship between Drug Holidays of Antiresorptive Agents and Surgical Outcomes in Cancer Patients with Medication-Related Osteonecrosis of the Jaw
Mitsunobu Otsuru, Sakiko Soutome, Keisuke Omori, Koki Suyama, Kota Morishita, Saki Hayashida, Maho Murata, Yukinori Takagi, Miho Sasaki, Misa Sumi, Yuka Kojima, Shunsuke Sawada, Yuki Sakamoto, Masahiro Umeda
International Journal of Environmental Research and Public Health.2022; 19(8): 4624. CrossRef The Role of Geranylgeraniol in Managing Bisphosphonate-Related Osteonecrosis of the Jaw
Kok-Yong Chin, Sophia Ogechi Ekeuku, Anne Trias
Frontiers in Pharmacology.2022;[Epub] CrossRef Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study
Sakiko Soutome, Mitsunobu Otsuru, Maho Murata, Kota Morishita, Keisuke Omori, Koki Suyama, Saki Hayashida, Masahiro Umeda, Toshiyuki Saito
Supportive Care in Cancer.2022; 30(9): 7241. CrossRef Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
E. M. Spevak, D. Yu. Christophorando, V. A. Shutov, A. V. Ermakova
Creative surgery and oncology.2022; 12(2): 151. CrossRef Ineffectiveness of Antiresorptive Agent Drug Holidays in Osteoporosis Patients for Treatment of Medication-Related Osteonecrosis of the Jaw: Consideration from Immunohistological Observation of Osteoclast Suppression and Treatment Outcomes
Keisuke Omori, Mitsunobu Otsuru, Kota Morishita, Saki Hayashida, Koki Suyama, Tomofumi Naruse, Sakiko Soutome, Masahiro Umeda
International Journal of Environmental Research and Public Health.2022; 19(17): 10898. CrossRef
|